Endo (NDOI) Price-to-Operating-Cash-Flow : 1,410.00 (As of May. 29, 2025)

View and export this data going back to 2024. Start your Free Trial

What is Endo Price-to-Operating-Cash-Flow?

As of today (2025-05-29), Endo's share price is $21.15. Endo's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was $0.02. Hence, Endo's Price-to-Operating-Cash-Flow Ratio for today is 1,410.00.

The historical rank and industry rank for Endo's Price-to-Operating-Cash-Flow or its related term are showing as below:

NDOI' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.82 Med: 11.2 Max: 1483.33
Current: 1410.01

During the past 3 years, Endo's highest Price-to-Operating-Cash-Flow Ratio was 1483.33. The lowest was 5.82. And the median was 11.20.

NDOI's Price-to-Operating-Cash-Flow is ranked worse than
99.57% of 691 companies
in the Drug Manufacturers industry
Industry Median: 17.15 vs NDOI: 1410.01

Endo's Cash Flow from Operations per share for the three months ended in Mar. 2025 was $0.02. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was $0.02.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Endo was -99.70% per year.

Endo Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Endo's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo Price-to-Operating-Cash-Flow Chart

Endo Annual Data

Trend

Dec22

Dec23

Dec24

Price-to-Operating-Cash-Flow

Endo Quarterly Data
	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial			-	6.57	11.41	-	1,600.00

Competitive Comparison of Endo's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Endo's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Endo's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Endo's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Endo's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Endo Price-to-Operating-Cash-Flow Calculation

Endo's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	21.15	/	0.015
	=	1,410.00

Endo's Share Price of today is $21.15.
Endo's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Endo Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Endo's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Endo Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo Inc (OTCPK:NDOI) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Great Valley Parkway, Malvern, PA, USA, 19355

Website

https://www.endo.com

Endo Inc is a diversified pharmaceutical company. It has four reportable business segments: (1) Branded Pharmaceuticals, (2) Sterile Injectables, (3) Generic Pharmaceuticals and (4) International Pharmaceuticals. Branded Pharmaceuticals segment includes a variety of branded products in the therapeutic areas of urology, orthopedics, etc. Sterile Injectables segment consists of branded sterile injectable products such as ADRENALIN, VASOSTRICT and APLISOL, among others. Generic Pharmaceuticals segment includes a product portfolio including patches, solid oral extended-release products, etc. Key revenue is generated from International Pharmaceuticals segment includes a variety of specialty pharmaceutical products, including OTC products, sold outside the U.S.